| PHYSICIANS’ CONFERENCE PROGRAM | ||||||||
| May 05, 2023 (Friday) – Hall A (Grand Ballroom 03) | ||||||||
| (The timings mentioned are as per the Indian Standard Time – IST) | ||||||||
| Time (IST) | Topic | Faculty | ||||||
| 09:00 AM – 10:30 AM | Session 1: Leukaemia |
Chairs: Dr Sanjeevan Sharma, Dr Krishna Ratnam |
||||||
| 09:00 AM – 09:30 AM | HSCT in MPN and it’s allies | Dr Tania Jain | ||||||
| 09:30 AM – 10:00 AM | HSCT for AML in the molecular era | Dr Vikram Mathews | ||||||
| 10:00 AM – 10:30 AM | Debate: RIC Vs MAC for AML |
Dr Ranjit Sahoo, Dr Rishi Dhawan |
||||||
| 10:30 AM – 11:00 AM | Coffee Break | |||||||
| 11:00 AM – 11:15 AM | Inaugural Ceremony | |||||||
| 11:15 AM – 01:15 PM | Session 2: Joint Session of ISBMT with EBMT, ASTCT & APBMT |
Chairs: Dr Amir Ali Hamidieh, Dr Tapan Saikia, Dr Anna Sureda, Dr Uday R Popat |
||||||
| 11:15 AM – 11:45 AM | Unravelling Fanconi Anaemia Biology | Dr Shaji RV | ||||||
| 11:45 AM – 12:15 PM | Individualised HSCT for Fanconi Anaemia | Dr Parinda Mehta | ||||||
| 12:15 PM – 12:45 PM | Unravelling the DNA in marrow failure | Dr Hideki Muramatsu | ||||||
| 12:45 PM – 01:15 PM | Inherited bone marrow failure syndromes | Dr Carlo Dufour | ||||||
| 01:15 PM – 02:00 PM | Industry Lunch Symposium – Emcure (Theme: Treosulfan Across the Ages) |
|||||||
| 01:15 PM – 01:20 PM | Introduction | Dr Sunil Bhat | ||||||
| 01:20 PM – 01:30 PM | Treosulfan in Children less than 2 years | Dr Satya P Yadav | ||||||
| 01:30 PM – 01:40 PM | Treosulfan in patients with co-morbidity | Dr Padmaja Lokireddy | ||||||
| 01:40 PM – 01:50 PM | Treosulfan in the elderly | Dr Sameer Melinkeri | ||||||
| 01:50 PM – 02:00 PM | Panel discussion | Moderator: Dr Sunil Bhat Panelists: Dr Satya P Yadav, Dr Padmaja Lokireddy, Dr Sameer Melinkeri |
||||||
| 02:00 PM – 03:30 PM | Session 3: Lymphoma/ Myeloma |
Chairs: Dr Ajay Sharma, Dr Arijit Nag |
||||||
| 02:00 PM – 02:30 PM | CAR-T in Myeloma | Dr Dinesh Bhurani | ||||||
| 02:30 PM – 03:00 PM | Double Hit NHL: CART- T Vs. Auto Transplant |
Dr Anant Gokarn, Dr Punit Jain |
||||||
| 03:00 PM – 03:30 PM | Debate: Autologous HSCT vs. Check point inhibitors in relapsed Hodgkin’s Lymphoma |
Dr Atul Sharma, Dr Pankaj Malhotra |
||||||
| 03:30 PM – 05:00 PM | Session 4: Paediatric Session |
Chairs: Dr Deenadayalan M, Dr Anand Prakash |
||||||
| 03:30 PM – 04:00 PM | How I transplant SCID | Dr Fouzia NA | ||||||
| 04:00 PM – 04:30 PM | How I transplant Fanconi anaemia | Dr Carmem Bonfim | ||||||
| 04:30 PM – 05:00 PM | Debate: PTCY versus TCR alpha beta for infants |
Dr Prashant Hiwarkar, Dr Satyendra Katewa |
||||||
| 05:00 PM – 06:00 PM | Poster Session | Judges:
Dr Chandran Nair & Dr Santosh Kumar & Dr Ramasawamy NV & Dr Venkatesh Ekbote & Dr Shivani Patel & Dr Sanjeevan Sharma & Dr Pankaj Malhotra & |
||||||
| 06:00 PM – 07:30 PM | ISBMT Registry Meeting and AGM | |||||||
| 07:45 PM – 08:30 PM | Industry Symposium – Cipla (Theme: Smart Solutions for Super Bugs) |
|||||||
| 07:45 PM – 07:50 PM | Introduction | Dr Mammen Chandy | ||||||
| 07:50 PM – 08:00 PM | The Spectrum of Multi Drug Resistant Bacterial Infections in HSCT in India | Dr Sushil Selvarajan | ||||||
| 08:00 PM – 08:10 PM | EDTA and Biocide combination | Dr Lingaraj Nayak | ||||||
| 08:10 PM – 08:20 PM | AVIBACTAM – The Augmenting Force | Dr Ruchira Misra | ||||||
| 08:20 PM – 08:30 PM | Panel discussion | Moderator:
Dr Mammen Chandy Panelists: Dr Sushil Selvarajan, |
||||||
| 08:30 PM onwards | Dinner | |||||||
| PHYSICIANS’ CONFERENCE PROGRAM | |||||
| May 06, 2023 (Saturday) | |||||
| (The timings mentioned are as per the Indian Standard Time – IST) | |||||
| Hall A (Grand Ballroom 03) | Hall B (Studio 06) | ||||
| Time (IST) | Topic | Faculty | Time | Topic | Faculty |
| 08:00 AM – 09:00 AM | Meet The Experts | ||||
| Aplastic Anaemia | Dr Parinda Mehta, Dr Carmem Bonfim, Dr Intezar Mehdi, Dr Manas Kalra |
||||
| How I transplant a patient with ALL | Dr Sameer Melinkeri, Dr Jose Easow, Dr Sanjeevan Sharma, Dr Krishnarathnam Kannan |
||||
| 09:00 AM – 10:45 AM | Session 5: Cellular Therapy |
Chairs: Dr Alok Srivastava, Dr Seema Bhatwadekar |
|||
| 09:00 AM – 09:20 AM | CAR T in lymphoma | Sharat Damodar | |||
| 09:20 AM – 09:40 AM | Gene therapy for SCID | Gaurav Kharya | |||
| 09:40 AM – 10:00 AM | CMV specific CTL | Uday Kulkarni | |||
| 10:00 AM – 10:20 AM | CAR T in ALL | Sunil Bhat | |||
| 10:20 AM – 10:45 AM | Q&A | ||||
| 10:45 AM – 11:00 AM | BREAK | ||||
| 11:00 AM – 11:45 AM | Industry Symposium – Takeda Pharmaceuticals (Theme: Bringing Hope in Relapsed Refractory Hodgkin’s Lymphoma Patients) |
11:00 AM – 11:45 AM | Industry Symposium – Pfizer (Theme: Innovative Options for Relapsed Refractory ALL) |
||
| 11:00 AM – 11:20 AM | Role of Adcetris post 1st Salvage in Relapsed Refractory cHL | Dr Sharat Damodar | 11:00 AM – 11:15 AM | Recent Advances in Therapy For Relapsed Refractory ALL | Dr Hari Menon |
| 11:20 AM – 11:45 AM | Panel Discussion: How to Optimize Treatment Outcomes in R/R HL – Case based approach |
Moderator: Dr Dinesh BhuraniPanelists: Dr Sameer Melinkeri, |
11:15 AM – 11:45 AM | Case Based Panel Discussion | Moderator:
Dr Rayaz Ahmed Panelists: Dr Hari Menon, |
| 11:45 AM – 01:30 PM | Session 7 | 11:45 AM – 01:30 PM | Session 6: | Chairs: Dr Hari Menon, Dr Sandip Shah, Dr Ponni Sivaprakasam, Dr Mallikarjun Kalashetty |
|
| 11:45 AM – 12:15 PM | How to make our service seamless | Moderator: Mr Raghu Rajagopal Panellists: Dr Meera Achrekar, Mr Prathip Kumar, Dr Rasmi Palassery, Ms Saranya Srinivasan |
11:45 AM – 11:53 AM | Randomized Controlled Trial of Pre-Transplant Zoledronate versus Observation for Prevention of Bone Loss in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation (Abstract ID: 84) | Urmimala Bhattacharjee |
| 11:53 AM – 12:01 PM | Real Word Experience Of Allogenic Stem Cell Transplant In Bone Marrow Failure: A Single Centre Experience (Abstract ID: 110) | Shreya Gopal Agrawal | |||
| 12:01 PM – 12:09 PM | Effect of conditioning regimen in the overall survival of individuals undergoing Haploidentical Stem Cell Transplantation: A Retrospective study from a tertiary care hospital in South India (Abstract ID: 113) | Gohul GJ | |||
| 12:09 PM – 12:17 PM | Experience of Haplo SCT using GIAC protocol from tertiary care centre in North India (Abstract ID: 109) | Sravan Dubasi | |||
| 12:15 PM – 12:35 PM | Challenges in Apheresis | Dr Lakshman V | 12:17 PM – 12:25 PM | Haploidentical Peripheral Blood Stem Cell Transplant with Fludarabine – Myeloablative Total Body Irradiation as Conditioning Regimen with Post-Transplant Cyclophosphamide – A Single Centre Experience (Abstract ID: 102) | Pragadeesh Thamarai Selvan |
| 12:25 PM – 12:33 PM | Conditioning with Fludarabine-Melphalan has better outcomes in Allogeneic Hematopoietic stem cell transplantation (HSCT) for Acute Myeloid Leukemia (AML) (Abstract ID: 97) | Rajat Pincha | |||
| 12:35 PM – 12:55 PM | Cryopreservation | Dr Satyam Arora | 12:33 PM – 12:41 PM | Randomized Controlled Trial of Fructo-Oligosaccharides (FOS) versus Observation to Restore Gut Microbiome and Improve Outcomes in Allogeneic Hematopoietic Cell Transplantation (Abstract ID: 06) | Deepesh Lad |
| 12:41 PM – 12:49 PM | Molecular Patterns of Resistance in Carbapenem Resistant Organisms detected in Stool Surveillance Cultures in patients undergoing Hematopoietic Cell Transplant (Abstract ID: 90) | Koustubh Kuber Shekar | |||
| 12:55 PM – 01:15 PM | Quality in HSCT | Dr Mammen Chandy | 12:49 PM – 12:57 PM | Risk factors for Transplant Associated Thrombotic Microangiopathy (TA-TMA) among patients with Philadelphia positive (Ph+) leukemias undergoing Allogeneic Stem Cell Transplant (ASCT) (Abstract ID: 81) | Anant Gokarn |
| 12:57 PM – 01:05 PM | TCR alpha beta haploidentical hematopoietic stem cell transplantation in inborn errors of immunity and the role of CD34 boost in improving immune reconstitution and survival (Abstract ID: 69) | Venkateswaran V S | |||
| 01:05 PM – 01:13 PM | Novel Pre Transplant Immunosuppression In children with Thalassemia Major undergoing Allogeneic Hematopoietic Stem Cell Transplant- a retrospective study from Tertiary Care Center In India (Abstract ID: 62) | Shweta Pathak | |||
| 01:15 PM – 01:30 PM | Q&A | 01:13 PM – 01:21 PM | Ten-year follow up study of children with thalassaemia major post transplantation using treosulfan, thiotepa, fludarabine based conditioning regimen and its impact on growth and puberty (Abstract ID: 59) | Kavitha Ganesan | |
| 01:30 PM – 01:45 PM | Valedictory | ||||
| 01:45 PM Onwards | Lunch and Departures | ||||
